|
1
|
Kuzminov A: Inhibition of DNA synthesis
facilitates expansion of low-complexity repeats: Is strand slippage
stimulated by transient local depletion of specific dNTPs?
Bioessays. 35:306–313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu X and Meltzer SJ: Gastric cancer in
the era of precision medicine. Cell Mol Gastroenterol Hepatol.
3:348–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan WY, Hu J, Xie L, Cheng L, Yang M, Li
L, Shi J, Liu BR and Qian XP: Prediction of biological behavior and
prognosis of colorectal cancer patients by tumor MSI/MMR in the
Chinese population. Onco Targets Ther. 9:7415–7424. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Worthley DL and Leggett BA: Colorectal
cancer: Molecular features and clinical opportunities. Clin Biochem
Rev. 31:31–38. 2010.PubMed/NCBI
|
|
6
|
Parikh N, Hilsenbeck S, Creighton CJ,
Dayaram T, Shuck R, Shinbrot E, Xi L, Gibbs RA, Wheeler DA and
Donehower LA: Effects of TP53 mutational status on gene expression
patterns across 10 human cancer types. J Pathol. 232:522–533. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silwal-Pandit L, Vollan HK, Chin SF, Rueda
OM, McKinney S, Osako T, Quigley DA, Kristensen VN, Aparicio S,
Børresen-Dale AL, et al: TP53 mutation spectrum in breast cancer is
subtype specific and has distinct prognostic relevance. Clin Cancer
Res. 20:3569–3580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Köbel M, Piskorz AM, Lee S, Lui S, LePage
C, Marass F, Rosenfeld N, Mes Masson AM and Brenton JD: Optimized
p53 immunohistochemistry is an accurate predictor of TP53 mutation
in ovarian carcinoma. J Pathol Clin Res. 2:247–258. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saha MN, Qiu L and Chang H: Targeting p53
by small molecules in hematological malignancies. J Hematol Oncol.
6:232013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smith G, Carey FA, Beattie J, Wilkie MJ,
Lightfoot TJ, Coxhead J, Garner RC, Steele RJ and Wolf CR:
Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways
to colorectal cancer. Proc Natl Acad Sci USA. 99:9433–9438. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan
CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, et al:
Deletions linked to TP53 loss drive cancer through p53-independent
mechanisms. Nature. 531:471–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Futreal PA, Barrett JC and Wiseman RW: An
Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res.
19:69771991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du X, Chen Z, Li W, Tan Y, Lu J, Zhu X,
Zhao T, Dong G and Zeng L: Development of novel microsatellite DNA
markers by cross-amplification and analysis of genetic variation in
gerbils. J Hered. 101:710–716. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fodde R, Smits R and Clevers H: APC,
signal transduction and genetic instability in colorectal cancer.
Nat Rev Cancer. 1:55–67. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müller MF, Ibrahim AE and Arends MJ:
Molecular pathological classification of colorectal cancer.
Virchows Arch. 469:125–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamat N, Khidhir MA, Jaloudi M, Hussain S,
Alashari MM, Al Qawasmeh KH and Rannug U: High incidence of
microsatellite instability and loss of heterozygosity in three loci
in breast cancer patients receiving chemotherapy: A prospective
study. BMC Cancer. 12:3732012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hahn M, Fislage R and Pingoud A:
Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1
of the human tumor suppressor gene p53 (17p13.1). Hum Genet.
95:471–472. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wangefjord S, Brändstedt J, Lindquist KE,
Nodin B, Jirström K and Eberhard J: Associations of beta-catenin
alterations and MSI screening status with expression of key cell
cycle regulating proteins and survival from colorectal cancer.
Diagn Pathol. 8:102013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jass JR: Classification of colorectal
cancer based on correlation of clinical, morphological and
molecular features. Histopathology. 50:113–130. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salahshor S, Kressner U, Fischer H,
Lindmark G, Glimelius B, Påhlman L and Lindblom A: Microsatellite
instability in sporadic colorectal cancer is not an independent
prognostic factor. Br J Cancer. 81:190–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Samowitz WS, Curtin K, Neuhausen S,
Schaffer D and Slattery ML: Prognostic implications of BAX and
TGFBRII mutations in colon cancers with microsatellite instability.
Genes Chromosomes Cancer. 35:368–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bougeard G, Renaux-Petel M, Flaman JM,
Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M,
Stoppa-Lyonnet D, Consolino E, Brugières L, et al: Revisiting
Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol.
33:2345–2352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dantzer J, Moad C, Heiland R and Mooney S:
MutDB services: Interactive structural analysis of mutation data.
Nucleic Acids Res. 33:W311–W314. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramensky V, Bork P and Sunyaev S: Human
non-synonymous SNPs: Server and survey. Nucleic Acids Res.
30:3894–3900. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krammer PH: CD95's deadly mission in the
immune system. Nature. 407:789–795. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamura G: Genetic and epigenetic
alterations of tumor suppressor and tumor-related genes in gastric
cancer. Histol Histopathol. 17:323–329. 2002.PubMed/NCBI
|
